Development of small molecule drugs – from the clinic to the market
In this webinar, an overview of the development and lifecycle of a small molecule drug is presented. Attention is then turned to the typical needs and requirements for an API manufacturer at each stage of the lifecycle. We then present a case study of how a CMO, such as Cambrex, has the expertise to support customers at all stages from early development to commercial launch.
Daniel M. Bowles, Ph.D. Senior Director, Chemical Development, Cambrex
Michael Tracey, Ph.D. Principal Scientist, New Product Development, Cambrex